Investment Summary

Inflexion Invests In YER

On December 23, 2022, private equity firm Inflexion invested in staffing company YER

Investment Highlights
  • This is Inflexion’s 4th transaction in the Staffing sector.
  • This is Inflexion’s 3rd transaction in the Netherlands.

Investment Summary

Date 2022-12-23
Target YER
Sector Staffing
Investor(s) Inflexion
Deal Type Growth Capital

Target

YER

Amsterdam, Netherlands
YER is a specialist secondment and recruiting agency. YER was founded in 1987 and is based in Amsterdam, Netherlands.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Inflexion

London, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1999
PE ASSETS 10.0B GBP
Size Mega
Type Sector Agnostic
DESCRIPTION

Inflexion is a private equity firm that specializes in investments in UK-based founder and family-owned businesses. Broad areas of interest include consumer products/services, business services, healthcare, industrials, technology, and financial services. The Firm's target investment size is £10 to £500 million. Inflexion was formed in 1999 and is based in London.


DEAL STATS #
Overall 105 of 124
Sector: Staffing M&A 4 of 4
Type: Growth Capital M&A Deals 24 of 32
Country: Netherlands M&A 3 of 4
Year: 2022 M&A 9 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-30 Phenna Group

Nottingham, United Kingdom

Phenna Group consists of a broad range of testing, inspection, certification and compliance (TICC) businesses currently serving industrial manufacturing, and built environment markets. Phenna Group was founded in 2018 and is based in Nottingham, United Kingdom.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-09 Proteros

Martinsried, Germany

Proteros is a contract research organisation focused on early-stage drug discovery specialist in structural biology and has created a cutting-edge platform recognised globally by both large pharma and biotechs as capable of unlocking the most technically challenging drug targets. Proteros was founded in 2000 and is based in Martinsried, Germany.

Buy -